SEC Form 4 · accession 0001179110-16-019499
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jared Watkin
Officer — Senior Vice President
Period of report
Feb 15, 2016
Accepted (ET)
Feb 17, 2016 · 5:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Feb 15, 2016 | F | 606 | $37.13 | D | 30,801 | D | |
| Common shares without par value | Feb 16, 2016 | S | 207 | $37.13 | D | 30,594 | D | |
| Common shares without par valueF1 | holding | — | — | — | 391 | I | Profit Sharing Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of February 16, 2016.
Remarks
The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).